tiprankstipranks
PHARMABEES
Nippon India Nifty Pharma ETF Units Exchange Traded Fund
Advertisement

IN:PHARMABEES ETF Technical Analysis

Compare

Summary of all the Indicators

Summary
Buy
12Bullish
4Neutral
4Bearish
Oscillators
Buy
4Bullish
4Neutral
2Bearish
Moving Averages
Strong Buy
8Bullish
0Neutral
2Bearish
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) Moving Averages Convergence Divergence (MACD) indicator is 0.56, suggesting Nippon India Nifty Pharma ETF Units Exchange Traded Fund is a Sell.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 20-Day exponential moving average is 24.70, making it a Buy.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 50-Day exponential moving average is 23.99, making it a Buy.

Nippon India Nifty Pharma ETF Units Exchange Traded Fund (PHARMABEES) Pivot Points

May 24, 2026, 08:15 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
24.87
25.10
25.30
25.53
25.73
25.96
26.16
Fibonacci
25.10
25.26
25.36
25.53
25.69
25.79
25.96

Nippon India Nifty Pharma ETF Units Exchange Traded Fund (PHARMABEES) Moving Averages

May 24, 2026, 08:15 PM
Period
Simple
Exponential
MA5
25.44Sell
25.33Sell
MA10
25.15Buy
25.14Buy
MA20
24.63Buy
24.70Buy
MA50
23.68Buy
23.99Buy
MA100
23.35Buy
23.58Buy
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 10-Day exponential moving average is 25.14, making it a Buy.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 100-Day exponential moving average is 23.58, making it a Buy.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 50-day simple moving average is 23.68, creating a Buy signal.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 100-day simple moving average is 23.35, creating a Buy signal.

Nippon India Nifty Pharma ETF Units Exchange Traded Fund (PHARMABEES) Technical Analysis

May 24, 2026, 08:15 PM
Name
Value
Action
RSI (14)
65.02
Neutral
STOCH (9,6)
76.45
Neutral
STOCHRSI (14)
83.62
Sell
MACD (12,26)
0.56
Sell
ADX (14)
16.08
Buy
Williams %R
-29.44
Buy
CCI (14)
93.89
Neutral
ATR (14)
0.64
-
Ultimate Oscillator
58.51
Neutral
ROC
4.73
Buy
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) Relative Strength Index (RSI) is 65.02, creating a Neutral signal.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) Trend Strength Indicator (ADX) is 16.08, creating a Buy signal.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) Commodity Channel Index (CCI) is 93.89, creating a Neutral signal.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) Price Rate of Change (ROC) is 4.73, creating a Buy signal.

FAQ

Is PHARMABEES a Buy, Hold, or Sell?
Based on PHARMABEES’s technical indicators, PHARMABEES is a Buy.
    What is PHARMABEES’s RSI (14)?
    PHARMABEES’s RSI (14) is 65.02, which suggests PHARMABEES is a Neutral.
      What is PHARMABEES’s MACD?
      PHARMABEES’s MACD is 0.56, which suggests PHARMABEES is a Sell.
        What is PHARMABEES’s 5-day moving average?
        PHARMABEES’s 5-day moving average is 25.44, which suggests PHARMABEES is a Sell.
          What is PHARMABEES’s 20-day moving average?
          PHARMABEES 20-day moving average is 24.63, which suggests PHARMABEES is a Buy.
            What is PHARMABEES’s 50-day moving average?
            PHARMABEES’s 50-day moving average is 23.68, which suggests PHARMABEES is a Buy.
              What is PHARMABEES’s 200-day moving average?
              Currently, no data Available
              What is PHARMABEES’s Williams % R (14)?
              PHARMABEES’s Williams % R (14) is -29.44, which suggests PHARMABEES is a Buy.
                What is PHARMABEES’s CCI (14)?
                PHARMABEES’s CCI (14) is 93.89, which suggests PHARMABEES is a Neutral.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis
                  Advertisement